Welcome to the School of Pharmacy's research pages. Here, you will find details of the diverse range of world-leading research programmes conducted in our School. In the 2014 REF (UK Research Assessment Framework - national assessment of university research quality), 92% of our research was judged as world leading or internationally excellent, ranking us as one of the leading academic centres for Pharmacy research in the UK. Click here for details.
Our new Research Prospectus is now available, downloadable as a PDF.
We hope you enjoy reading these pages and finding out more about our work, whether as a prospective student, employee, collaborator or funder.
Professor Chris Scott has developed a new treatment to stop one of the UK's biggest killers - Acute Respiratory Distress Syndrome (ARDS). Click here to watch him talk about it.
Click here for an interview with Professor Ryan Donnelly, winner of the 2013 BBSRC ‘Innovator of the Year’ award for his research on transdermal drug delivery using microneedles.
Click here to watch Professor Tracy Robson as she talks about her ground-breaking research to develop a new anti-cancer drug.
Click here to watch a demonstration of ‘VaccineTab’, Dr. Vicky Kett’s novel nasal vaccine delivery system
Pharmacy is a multidisciplinary subject; hence you will see that we are working on aspects of social sciences, clinical sciences, physicochemical sciences and even engineering! As a Pharmacy school, we focus on drugs to prevent, alleviate or cure diseases and our research programmes range from drug design and discovery, to formulation and delivery, and on to action and use. Increasingly, many aspects of our research are carried out in collaboration with world leading colleagues and research centres in Europe, Asia and North America.
Our research is organised under two divisions or clusters - Pharmaceutical Science and Practice, and Molecular Therapeutics. Both clusters have a number of key themes and associated research programmes which are mainly funded by UK and European Government sources, leading medical charities and the pharmaceutical industry. Our ultimate aim is to deliver real benefits for patients from our academic research programmes. Thus, we value highly the translational aspects of research.